Your browser is no longer supported. Please, upgrade your browser.
MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E29.99 EPS (ttm)3.47 Insider Own0.23% Shs Outstand1.35B Perf Week-3.09%
Market Cap140.74B Forward P/E16.94 EPS next Y6.15 Insider Trans-4.44% Shs Float1.34B Perf Month1.23%
Income4.70B PEG2.62 EPS next Q1.37 Inst Own83.00% Short Float0.87% Perf Quarter-15.69%
Sales31.80B P/S4.43 EPS this Y-26.10% Inst Trans0.13% Short Ratio1.66 Perf Half Y-20.00%
Book/sh38.65 P/B2.70 EPS next Y8.16% ROA5.00% Target Price128.76 Perf Year-10.78%
Cash/sh7.90 P/C13.19 EPS next 5Y11.46% ROE9.10% 52W Range98.38 - 135.89 Perf YTD0.70%
Dividend2.52 P/FCF55.89 EPS past 5Y0.80% ROI4.90% 52W High-23.34% Beta0.75
Dividend %2.42% Quick Ratio2.40 Sales past 5Y0.90% Gross Margin68.00% 52W Low5.89% ATR2.55
Employees90000 Current Ratio2.90 Sales Q/Q2.60% Oper. Margin16.70% RSI (14)39.68 Volatility3.02% 2.17%
OptionableYes Debt/Eq0.49 EPS Q/Q167.50% Profit Margin14.80% Rel Volume1.20 Prev Close104.21
ShortableYes LT Debt/Eq0.49 EarningsNov 23 BMO Payout69.20% Avg Volume7.04M Price104.17
Recom2.00 SMA20-1.75% SMA50-4.22% SMA200-14.90% Volume8,419,820 Change-0.04%
Jan-10-22Downgrade BTIG Research Buy → Neutral
Jan-07-22Downgrade Morgan Stanley Overweight → Equal-Weight $145 → $120
Jan-04-22Downgrade Piper Sandler Overweight → Neutral $152 → $110
Dec-17-21Downgrade JP Morgan Overweight → Neutral $130 → $105
Dec-16-21Downgrade Wells Fargo Overweight → Equal Weight $137 → $110
Dec-10-21Initiated RBC Capital Mkts Outperform $140
Jun-10-21Resumed Cowen Outperform $141
May-25-21Initiated Barclays Equal Weight $145
Apr-15-21Initiated Atlantic Equities Overweight $153
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
Feb-13-20Initiated Goldman Sell $118
Jan-08-20Initiated SunTrust Buy $130
Jan-25-22 01:38PM  
09:38AM  
Jan-24-22 05:38PM  
05:38PM  
01:38PM  
01:38PM  
11:00AM  
09:52AM  
Jan-22-22 10:01AM  
Jan-21-22 05:38PM  
12:47PM  
11:55AM  
10:32AM  
09:38AM  
Jan-20-22 05:50PM  
05:38PM  
01:38PM  
01:05PM  
Jan-19-22 09:38PM  
01:38PM  
09:38AM  
09:38AM  
09:38AM  
Jan-18-22 03:06PM  
01:38PM  
01:38PM  
09:38AM  
Jan-17-22 09:04AM  
08:36AM  
06:52AM  
Jan-15-22 09:40AM  
Jan-14-22 01:10PM  
12:00PM  
11:37AM  
09:38AM  
Jan-13-22 09:38AM  
Jan-12-22 05:50PM  
05:38PM  
11:10AM  
09:38AM  
09:00AM  
08:03AM  
Jan-11-22 09:24AM  
06:36AM  
Jan-10-22 08:00PM  
04:00PM  
01:38PM  
09:51AM  
08:34AM  
08:00AM  
07:00AM  
07:00AM  
Jan-07-22 09:40AM  
Jan-06-22 09:38PM  
03:55AM  
Jan-05-22 05:38PM  
01:38PM  
06:15AM  
Jan-04-22 05:50PM  
01:38PM  
11:00AM  
09:50AM  
Dec-29-21 06:15PM  
Dec-28-21 08:35AM  
Dec-27-21 09:38PM  
12:52PM  
06:00AM  
Dec-23-21 11:30AM  
11:15AM  
08:28AM  
07:52AM  
Dec-22-21 09:07AM  
07:56AM  
Dec-21-21 10:17AM  
Dec-20-21 09:00AM  
06:15AM  
Dec-18-21 08:38PM  
Dec-17-21 08:38PM  
10:00AM  
Dec-16-21 03:26PM  
12:52PM  
09:00AM  
07:45AM  
Dec-15-21 05:15PM  
04:12PM  
03:57PM  
03:32PM  
10:27AM  
09:34AM  
09:08AM  
07:29AM  
07:28AM  
06:45AM  
Dec-14-21 07:30AM  
07:30AM  
Dec-13-21 11:38PM  
02:16PM  
08:30AM  
Dec-11-21 06:38AM  
06:38AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 23Sale102.047,218736,52539,430Dec 27 06:31 PM
ANDERSON RICHARD HDirectorDec 16Buy103.265,010517,333108,374Dec 17 04:57 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 06Sale110.0068275,02035,446Dec 07 06:23 PM
Lerman Bradley ESVP General Counsel & Corp SecSep 30Option Exercise78.0049,1473,833,46697,910Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecSep 30Sale126.5849,1476,221,02748,763Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Option Exercise74.8450,7753,800,00199,538Sep 01 05:27 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Sale134.1750,7756,812,48248,763Sep 01 05:27 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Option Exercise38.7128,4191,100,06654,458Aug 26 07:28 PM
Martha GeoffreyCEOAug 25Option Exercise61.8111,581715,805105,936Aug 26 07:26 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Sale134.0828,4193,810,49233,329Aug 26 07:28 PM
Martha GeoffreyCEOAug 25Sale132.6711,5811,536,45195,836Aug 26 07:26 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 02Sale131.524,000526,08048,194Aug 04 06:18 PM
Martha GeoffreyCEOJun 28Option Exercise55.3211,500636,18093,448Jun 30 06:21 PM
Martha GeoffreyCEOJun 28Sale125.2911,5001,440,83581,948Jun 30 06:21 PM
Wall Brett A.EVP & Pres NeuroscienceJun 21Sale123.5011514,20221,602Jun 22 05:58 PM
Wall Brett A.EVP & Pres NeuroscienceJun 18Option Exercise74.841,16887,41322,655Jun 22 05:58 PM
PARKHILL KAREN LEVP & Chief Financial OfficerJun 15Sale124.4760575,30486,223Jun 17 06:11 PM
Wall Brett A.EVP & Pres NeuroscienceJun 01Sale128.072,473316,71721,487Jun 02 06:00 PM
Wall Brett A.EVP & Pres NeuroscienceMay 28Option Exercise47.0012,300578,10031,315Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Option Exercise82.7334,6562,866,92577,207Jun 01 05:55 PM
Liddicoat John REVP & President of AmericasMay 28Sale126.6534,6564,389,18242,551Jun 01 05:55 PM
Martha GeoffreyCEOApr 05Option Exercise52.5011,712614,92591,246Apr 07 04:28 PM
Martha GeoffreyCEOApr 05Sale118.8311,7121,391,73781,938Apr 07 04:28 PM
PARKHILL KAREN LEVP & Chief Financial OfficerMar 15Sale119.1263275,28486,556Mar 16 05:19 PM
TEN HOEDT ROBEVP & President EMEAMar 02Option Exercise34.887,168250,02050,965Mar 03 05:23 PM
TEN HOEDT ROBEVP & President EMEAMar 02Sale117.987,168845,68143,797Mar 03 05:23 PM